Graft-Versus-Host Disease — Trials, FDA Actions & Pivotal Research

20 active Graft-Versus-Host Disease trials currently recruiting in the US, sourced from ClinicalTrials.gov.

Synced daily from openFDA and ClinicalTrials.gov. Last sync: June 12, 2026.

Recruiting trials by city

Cities where Graft-Versus-Host Disease trials in our archive had recruiting sites. Each link lists every currently recruiting paid clinical trial at that location.

Duarte, CA Miami, FL Ann Arbor, MI Birmingham, AL Boston, MA Cleveland, OH Columbus, OH Detroit, MI Gainesville, FL Los Angeles, CA Palo Alto, CA San Diego, CA

Active Graft-Versus-Host Disease trials

Currently recruiting US trials matching Graft-Versus-Host Disease, sourced live from ClinicalTrials.gov. We’ll add per-event articles here as those trials post results or hit primary completion.

Evaluating the Effects of Propionate and Butyrate Supplementation on the Intestinal Health of Healthy Volunteers

for Graft Versus Host Disease

1 location in Duarte

Sponsor: City of Hope Medical Center

Sex: All·Age: 18 - 75·Accepts healthy volunteers

Code: NCT07611370·Phase 1·Not Yet Recruiting

A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD)

for Chronic Graft Versus Host Disease

Sponsor: Sanofi

Sex: All·Age: 12+

Code: NCT07135973·Phase 4·Not Yet Recruiting

TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

for GVHD

1 location in Palo Alto

Sponsor: Stanford University

Sex: All·Age: 18 - 80

Code: NCT07302776·Phase 1·Not Yet Recruiting

Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease

for Chronic Graft Versus Host Disease

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+

Code: NCT07535008·Recruiting

Apply to this trial

Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation

for Graft Versus Host Disease

1 location in Duarte

Sponsor: City of Hope Medical Center

Sex: All·Age: 7+

Code: NCT07235501·Not Yet Recruiting

Vorinostat for Graft-versus-host Disease (GVHD) Prevention in Non-Malignant Adolescent and Young Adults (AYA) Population

for GVHD

1 location in Ann Arbor

Sponsor: Sung Won Choi

Sex: All·Age: 1 - 26

Code: NCT06995521·Phase 2·Not Yet Recruiting

IL6-receptor Inhibitor Iwith Belumosudil for the Treatment of Belumosudil-refractory cGVHD

for cGVHD

Sponsor: Stanford University

Sex: All·Age: 18+

Code: NCT07484113·Phase 1·Not Yet Recruiting

Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant

for Acute Myeloid Leukemia

1 location in Duarte

Sponsor: City of Hope Medical Center

Sex: All·Age: 18 - 75

Code: NCT06996119·Phase 1·Recruiting

Apply to this trial

A Study of Ruxolitinib in Patients With Graft-Versus Host Disease

for Graft-Versus-Host Disease

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 0+

Code: NCT07594587·Recruiting

Apply to this trial

Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation

for Allogeneic HSCT

Sponsor: University Hospital Pilsen

Sex: All·Age: 18 - 70

Code: NCT07570407·Not Yet Recruiting

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

for Acute Myelogenous Leukemia

1 location in New York

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: Up to 26

Code: NCT07566377·Phase 2·Recruiting

Apply to this trial

Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation

for GVHD

1 location in San Diego

Sponsor: Scripps Health

Sex: All·Age: 18+

Code: NCT06590285·Recruiting

Apply to this trial

Gecacitinib in the Treatment of Steroid-Refractory/Dependent Chronic Graf Versus Host Disease (cGVHD).

for cGVHD

Sponsor: Institute of Hematology & Blood Diseases Hospital, China

Sex: All·Age: 18+

Code: NCT07476872·Phase 1, Phase 2·Not Yet Recruiting

A Clinical Study on the Efficacy and Safety of Ivarmacitinib in Preventing aGVHD After HLA-matched Transplantation

for aGVHD

Sponsor: Institute of Hematology & Blood Diseases Hospital, China

Sex: All·Age: 18 - 70

Code: NCT07381114·Phase 1, Phase 2·Not Yet Recruiting

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

for T-cell Lymphoma

1 location in Columbus

Sponsor: Jonathan Brammer

Sex: All·Age: 18+

Code: NCT07356245·Phase 2·Recruiting

Apply to this trial

Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHD

for Chronic Graft Versus Host Disease

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07127926·Recruiting

Apply to this trial

A Clinical Study Evaluating the Safety and Efficacy of GT729 Universal Cell Injection in the Treatment of Refractory or Relapsed Chronic Graft-versus-host Disease (cGVHD)

for cGVHD

Sponsor: Grit Biotechnology

Sex: All·Age: 18 - 65

Code: NCT07253259·EARLY_Phase 1·Recruiting

Apply to this trial

First-Line Jaktinib for Acute Graft-Versus-Host Disease (aGVHD)

for Acute Graft Versus Host Disease

Sponsor: First Affiliated Hospital of Zhejiang University

Sex: All·Age: 18+

Code: NCT07285889·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)

for Chronic Graft Versus Host Disease

5 locations incl. Los Angeles

Sponsor: Sanofi

Sex: All·Age: 1 - 18

Code: NCT07116031·Phase 2·Recruiting

Apply to this trial

Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD

for Chronic Graft Versus Host Disease

1 location in Durham

Sponsor: Stefanie Sarantopoulos, MD, PhD.

Sex: All·Age: 18 - 80

Code: NCT06233110·Phase 1·Recruiting

Apply to this trial